Investigation on the Clinical Use of Anti-Parkinson's Disease Drugs for Patients with Parkinson's Disease

王刚,周海燕,郑汭,谭玉燕,孙小康,王瑛,王增,陈生弟
DOI: https://doi.org/10.3969/j.issn.1004-1648.2006.05.006
2006-01-01
Journal of Clinical Neurology
Abstract:Objective To assess the clinical use of anti-Parkinson's disease(PD)drugs in the patients with PD,and provide a basis to formulate an effective clinical drug program.Methods 190 PD patients were interviewed by questionnaires about resources,dosage and costs of anti-PD drugs from April,2004 to March,2005.Results By retrospective analysis,number of drugs used in per patient per year was 2.88;levodopa dosage and Levodopa Equivalents(LDE)per patient were 323.0 mg/d and 318.6 mg/d respectively,and LDE increased significantly following by scores of Hoehn-Yahr(HY)class increasing(P0.01).Annual drug cost averaged approximately RMB 2597 Yuan per patient,and the factors that influenced drug cost were LDE and the number of drugs.Conclusion Levodopa and its compounds are the most important anti-PD drugs for clinical use,and dosage of LDE can be regarded as a sensitive marker to evaluate the disease progression and drug cost conditions.
What problem does this paper attempt to address?